Analytical Data
-
Gene name
ABHD14A
- Application
-
Alternative Names
ABHD14A; UNQ1913/PRO4373; Protein ABHD14A
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BUJ0
-
Expression Region
1-271aa
-
AA Sequence
MVGALCGCWFRLGGARPLIPLGPTVVQTSMSRSQVALLGLSLLLMLLLYVGLPGPPEQTSCLWGDPNVTVLAGLTPGNSPIFYREVLPLNQAHRVEVVLLHGKAFNSHTWEQLGTLQLLSQRGYRAVALDLPGFGNSAPSKEASTEAGRAALLERALRDLEVQNAVLVSPSLSGHYALPFLMRGHHQLHGFVPIAPTSTQNYTQEQFWAVKTPTLILYGELDHILARESLRQLRHLPNHSVVKLRNAGHACYLHKPQDFHLVLLAFLDHLP
-
Molecular Weight
29.7 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ABHD14A, a member of the serine hydrolase family, has gained significant attention in recent years due to its potential role in lipid metabolism and cellular signaling pathways. It is predominantly expressed in the brain and has been implicated in various physiological processes, including neurotransmitter regulation and the maintenance of neuronal integrity. Research indicates that ABHD14A may be involved in the hydrolysis of endocannabinoids, which are crucial for modulating synaptic transmission and neuroplasticity. Dysregulation of ABHD14A has been associated with several neurological disorders, making it a potential target for therapeutic interventions. The production of recombinant ABHD14A protein enables detailed structural and functional studies, facilitating the elucidation of its enzymatic mechanisms and interactions with lipid substrates. Understanding the biochemical properties and biological functions of ABHD14A could provide valuable insights into its role in health and disease, paving the way for novel treatment strategies in neurodegenerative and psychiatric disorders.











